Genomics

Dataset Information

0

Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy NA-seq (time course) May 15, 2018 approved TSV

ABSTRACT: Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy NA-seq (time course) May 15, 2018 approved TSV

PROVIDER: PRJNA387477 | ENA |

REPOSITORIES: ENA

Json Xml

Similar Datasets

Transcriptomics Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy NA-seq (time course) May 15, 2018 approved TSV
2018-05-15 | GSE99183 | GEO
Transcriptomics Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq)
2019-04-01 | GSE111252 | GEO
Genomics Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (ChIP-Seq)
2019-04-01 | GSE111253 | GEO
Genomics Bromodomain and Extraterminal Inhibition Blocks Inflammation-Induced Cardiac Dysfunction and SARS-CoV2 Infection
| PRJEB43658 | ENA
Genomics Burkholderia pseudomallei strain:TSV-377 | isolate:TSV-377
| PRJNA1032635 | ENA
Genomics Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma
| PRJNA436353 | ENA
Genomics The Bromodomain and extraterminal (BET) inhibitor attenuates inflammatory response and cell migration in human microglia
| PRJNA649597 | ENA
Genomics Burkholderia pseudomallei TSV 48
| PRJNA231196 | ENA
Genomics Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq)
| PRJNA436355 | ENA
Genomics Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (ChIP-Seq)
| PRJNA436354 | ENA